CAS 53-84-9 Nicotinamide Adenine Dinucleotide Nad+ IV Therapies Lyophilized Powder
129 Inquiries
53-84-9
Pharmaceutical Grade
99%
shenzhen
ZHONGMA
100mg*10vials 500mg*10vials 1000mg*10vials
2027-06-30
GLP-1,Retatrutide,Tirzepatide,Peptides
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceNAD+ is a coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage.
Solid
NAD zwitterion is a NAD. It has a role as a geroprotector. It derives from a deamido-NAD zwitterion. It is a conjugate base of a NAD(+).|A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed)|Nadide is a dinucleotide of adenine and nicotinamide. It has coenzyme activity in redox reactions and also acts as a donor of ADP-ribose moieties.Research & Reference NoteCAS 53-84-9 Nicotinamide Adenine Dinucleotide Nad+ IV Therapies Lyophilized Powder is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
Basic Info-
Product Name:
NAD
Other Name:Adenosine 5′-(trihydrogen diphosphate),P′→5′-ester with 3-(aminocarbonyl)-1-β-D-ribofuranosylpyridinium,inner salt;Pyridinium,3-carbamoyl-1-β-D-ribofuranosyl-,hydroxide,5′→5′-ester with adenosine 5′-(trihydrogen pyrophosphate),inner salt;Adenosine 5′-(trihydrogen diphosphate),P′→5′-ester with 3-(aminocarbonyl)-1-β-D-ribofuranosylpyridinium hydroxide,inner salt;Codehydrase I;Codehydrogenase I;Coenzyme I;Diphosphopyridine nucleotide;DPN;Cozymase I;NAD;Nadide;Nicotinamide-adenine dinucleotide;Oxidized diphosphopyridine nucleotide;Adenine-nicotinamide dinucleotide;NAD+;Enzopride;β-NAD;β-Diphosphopyridine nucleotide;β-Nicotinamide adenine dinucleotide;β-NAD+;NSC 20272;CO-I;β-Nicotinamide adenine dinucleotide hydrate;30429-30-2;159929-29-0;1083039-67-1;1354693-98-3
CAS No.:53-84-9
Molecular Formula:C21H27N7O14P2
InChIKeys:InChIKey=BAWFJGJZGIEFAR-NNYOXOHSSA-N
Molecular Weight:663.43
Exact Mass:663.109131
EC Number:200-184-4
NSC Number:757121
DSSTox ID:DTXSID2045236
NCI Thesaurus Code:C87339
HScode:29349990
Categories:
Characteristics-
PSA:
321
XLogP3:-1.29620
Appearance:White Powder
Melting Point:140-142 °C (decomp)
Water Solubility:soluble in water at 50mg/ml
Storage Conditions:2-8°C
Specific rotation:D20 -31.5° (c = 1.2 in water)
Collision Cross Section:226.7 Ų [M+H]+ [CCS Type: DT, Method: single field calibrated with Agilent tune mix (Agilent)]|227.5 Ų [M+H]+ [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|222.7 Ų [M+Na]+ [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|223.8 Ų [M-H]- [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|230.8 Ų [M+Na-2H]- [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|227 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Hazard IdentificationClassification of the substance or mixture
Not classified.
GHS label elements, including precautionary statements
Pictogram(s) No symbol. Signal word No signal word
Hazard statement(s) none
Precautionary statement(s) Prevention none
Response none
Storage none
Disposal none
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
GLP-1,Retatrutide,Tirzepatide,Peptides
-
Location:
Room A008, 704#, Building 11, Shiliu Street Block, Liangzhu Subdistrict, Yuhang District, Hangzhou City, Zhejiang Province
-
Payment Terms:
TT against copy of documents,100% TT in advance
-
Average lead Time:
1
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2025
-
-
Inquiry History129 Inquiries
Country Product Purchase Quantity Date Posted 
United States
holesale CAS 53-84-9 99% β-Nicotinamide adenine dinucleotide 99% white powder 99% WP
1 KG Feb 10, 2025
United States
Nad+ Injection 500mg/1000mg 99% Purity CAS 53-84-9 USP in 1000mg vials
1000 G Jan 12, 2024 
United Kingdom
Top Quality 99% Purity Nicotinamide Adenine Dinucleotide Powder Nad CAS 53-84-9 Nad+
5 G Oct 25, 2023
United Kingdom
NAD+
2 KG Mar 4, 2024 
India
ß-Nicotinamide Adenine Dinucleotide hydrate
1.00 KG Jan 29, 2026
India
Nicotinamide adenine dinucleotide
300.00 G Jan 10, 2024
United States
NAD+ lyophilized powder pure Pharacuetical Grade
500 G Apr 15, 2026
India
Nicotinamide Adenine Dinucleotide Iv Vials
1.00 KG Sep 12, 2023
India
beta-Diphosphopyridine nucleotide
100 KG Apr 16, 2024 
Philippines
NAD+
15 KG Sep 1, 2026
India
Nicotinamide Adenine Dinucleotide
25 KG Apr 7, 2025
Philippines
NAD+
15 KG Aug 31, 2026
United Kingdom
NAD+ 500mg for IV therapy
2 MG Aug 11, 2026
United States
NAD+
1000 MG Aug 4, 2026 
South Africa
Nad+
10 MT Jul 27, 2026
United States
NAD+ 500
10000 MG Jul 2, 2026
United States
Beta-Nicotinamide adenine dinucleotide Nad+
1 MG Jun 18, 2026 
Australia
Nad
10 MG Jun 16, 2026
United States
nad
1 G Jun 11, 2026
United States
NAD
1 G Jun 5, 2026 Post an enquiry for this product
- Hot Searches
- sodium hyaluronate supplier
- sr 17018 buy
- scopolamine powder for sale
- reta peptide for sale
- 18 46 0 fertilizer
- urea fertilizer price
- dapagliflozin propanediol 10 mg tablet
- magnesium oxide nanopowder market
- silicon price
- acetone chemical compound
- polytetramethylene glycol
- ammonia nitrate prill
